Solidigm looks set to be an important yardstick for whether to stay in the Korean market or move to the US market, and in what ratio to allocate.
I'm curious how it's progressing but there doesn't seem to be any information. I wish they would disclose the process transparently, including how they intend to resolve it. And not stab Korean-market investors in the back with a decision that leaves them in tears. Is that expecting too much
